Maurice Zauderer - Vaccinex CEO, CoFounder
Insider
Maurice Zauderer is CEO, CoFounder of Vaccinex
Age | 78 |
Phone | 585 271 2700 |
Web | https://www.vaccinex.com |
Maurice Zauderer Latest Insider Activity
Tracking and analyzing the buying and selling activities of Maurice Zauderer against Vaccinex stock is an integral part of due diligence when investing in Vaccinex. Maurice Zauderer insider activity provides valuable insight into whether Vaccinex is net buyers or sellers over its current business cycle. Note, Vaccinex insiders must abide by specific rules, including filing SEC forms every time they buy or sell Vaccinex'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Maurice Zauderer over two months ago Acquisition by Maurice Zauderer of 1877 shares of Vaccinex at 8.21 subject to Rule 16b-3 | ||
Maurice Zauderer over three months ago Acquisition by Maurice Zauderer of 46153 shares of Vaccinex at 3.25 subject to Rule 16b-3 | ||
Maurice Zauderer over six months ago Acquisition by Maurice Zauderer of 5000 shares of Vaccinex at 0.93 subject to Rule 16b-3 | ||
Maurice Zauderer over six months ago Acquisition by Maurice Zauderer of 38610 shares of Vaccinex at 7.64 subject to Rule 16b-3 |
Vaccinex Management Efficiency
The company has return on total asset (ROA) of (4.9564) % which means that it has lost $4.9564 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.5909) %, meaning that it created substantial loss on money invested by shareholders. Vaccinex's management efficiency ratios could be used to measure how well Vaccinex manages its routine affairs as well as how well it operates its assets and liabilities.Vaccinex currently holds 247 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Vaccinex has a current ratio of 8.06, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Vaccinex's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Steven Ruhl | Forte Biosciences | 68 | |
MBA MD | Surrozen | 56 | |
MBA MD | Monopar Therapeutics | 38 | |
Daniela Santiesteban | Salarius Pharmaceuticals | N/A | |
Nik Chetwyn | Erasca Inc | N/A | |
Eddie Sullivan | SAB Biotherapeutics | 59 | |
Scott Anderson | Anebulo Pharmaceuticals | N/A | |
MS JD | Surrozen | 62 | |
James Ahlers | RenovoRx | 60 | |
Angela Nelms | RenovoRx | 47 | |
David MD | Erasca Inc | 41 | |
David Hovland | Eledon Pharmaceuticals | N/A | |
Chandra Lovejoy | Erasca Inc | 53 | |
Andrew MBA | Monopar Therapeutics | 53 | |
Christine MBA | SAB Biotherapeutics | 69 | |
Edward DVM | SAB Biotherapeutics | N/A | |
Gregory Flesher | Eledon Pharmaceuticals | 54 | |
CPA MS | Erasca Inc | 55 | |
Antony CPA | Forte Biosciences | 58 | |
Ramtin MD | RenovoRx | 59 | |
McKee MD | GeoVax Labs | 72 |
Management Performance
Return On Equity | -7.59 | ||||
Return On Asset | -4.96 |
Vaccinex Leadership Team
Elected by the shareholders, the Vaccinex's board of directors comprises two types of representatives: Vaccinex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vaccinex. The board's role is to monitor Vaccinex's management team and ensure that shareholders' interests are well served. Vaccinex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vaccinex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jill CPA, Chief Officer | ||
Jill Sanchez, Interim Controller | ||
MBA CFA, Chief Officer | ||
Ernest Smith, Senior Officer | ||
Maurice Zauderer, CEO, CoFounder | ||
Elizabeth Evans, COO Medicine | ||
John Leonard, Senior Development |
Vaccinex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vaccinex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -7.59 | ||||
Return On Asset | -4.96 | ||||
Current Valuation | 1.59 M | ||||
Shares Outstanding | 2.68 M | ||||
Shares Owned By Insiders | 11.50 % | ||||
Shares Owned By Institutions | 51.30 % | ||||
Number Of Shares Shorted | 62.11 K | ||||
Price To Book | 7.34 X | ||||
Price To Sales | 4.34 X | ||||
Revenue | 570 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Vaccinex Stock
If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |